Supplementary Figure 1 from BCL-2 Family Inhibition Enhances mTORC1/2 Inhibition in PIK3CA-Mutant Colorectal Cancer
Year: 2025
Type: supplementary-materials
Abstract: Supplementary Figure 1. High-throughput drug screen displays reproducibility across drugs within the same drug class and known negative controls.
Authors: Rebecca A. DeStefanis, Alexa E. Schmitz, Alyssa K. Steimle, Susan N. Payne, Gioia C. Sha, Autumn M. Olson, Alec Cornelio, Anna E.L. Lippert, Sean G. Kraus, Katherine A. Johnson, Peter F. Favreau, Amani Gillette, Christopher Babiarz, Devon Miller, Carley M. Sprackling, Cheri A. Pasch, Stephanie Pritzl, Dana R. Van De Hey, Demetra P. Korkos, Tyler M. Foley, Alexander E. Yueh, Aurora L.J.X. Greane, Linda Clipson, Melissa C. Skala, Dustin A. Deming
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4416900020